MYGN 8.13 (-3.33%)
US62855J1043• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. MYGN

Myriad Genetics (MYGN) Competitor Comparison

We are evaluating the key criteria listed to compare Myriad Genetics (MYGN) against its competitors in the Diagnostics & Research industry.

Market Capitalization

28 / 58

Gross Profits

22 / 52

Total Revenue

25 / 57

EBITDA

51 / 56

Free Cashflow

42 / 56

Quick Ratio

44 / 57

Earnings per Share

40 / 56

Dividend yield

0 / 9

Total Cash

36 / 57

Performance 3 years

38 / 58

Performance 5 years

33 / 58

Performance 10 years

40 / 58

Linearity 3 years

25 / 58

Linearity 5 years

24 / 58

Linearity 10 years

24 / 58

Total Rank

23 / 58

Dividend Rank

22 / 58

Valuation Rank

28 / 58

Piotroski Rank

50 / 58

Muliplier Rank

56 / 58

Performance 5 years - MYGN ranking 33 / 58

These are the competitors of Myriad Genetics in the industry Diagnostics & Research ranked by performance 5 years
1. Lantheus Holdings LNTH
743.41
2. RadNet RDNT
459.77
3. Natera NTRA
361.46
4. Medpace Holdings MEDP
304.38
5. Meridian Bioscience VIVO
118.46
6. Laboratory Corp of America Holdings LH
117.56
7. Quest Diagnostics DGX
116.62
8. Waters WAT
73.92
9. Fulgent Genetics FLGT
66.93
10. DarioHealth DRIO
61.4
11. Anixa Biosciences ANIX
61.15
12. IDEXX Laboratories IDXX
59.88
13. Mettler-Toledo MTD
55.62
14. Thermo Fisher Scientific TMO
48.64
15. PerkinElmer PKI
48.44
16. Danaher DHR
46.46
17. IQVIA Holdings IQV
41.22
18. Agilent Technologies A
41.15
19. Twist Bioscience TWST
15.99
20. Icon ICLR
13.87
21. Ortho Clinical Diagnostics Holdings OCDX
13.74
22. Heska HSKA
12.14
23. Charles River Laboratories CRL
8.79
24. Co-Diagnostics CODX
6.45
25. Qiagen QGEN
-4.35
26. DexCom DXCM
-12.13
27. CareDx CDNA
-13.08
28. Syneos Health SYNH
-16.98
29. Olink Holding OLK
-26.82
30. Exact Sciences EXAS
-27.82
31. Inotiv NOTV
-29.64
32. Guardant Health GH
-35.97
33. Myriad Genetics MYGN
-36.19
34. Bioventus BVS
-44.83
35. Pacific Biosciences of California PACB
-55.6
36. Precipio PRPO
-57.29
37. Psychemedics PMD
-59.06
38. Personalis PSNL
-61.32
39. Sotera Health SHC
-61.7
40. NeoGenomics NEO
-65.23
41. Enzo Biochem ENZ
-65.26
42. Exagen XGN
-70.37
43. National Research NRC
-71.69
44. Illumina ILMN
-71.91
45. Neogen NEOG
-76.62
46. Sera Prognostics SERA
-78.75
47. Trinity Biotech TRIB
-81.02
48. MaxCyte MXCT
-85.58
49. Global Cord Blood CO
-86.47
50. Interpace Biosciences IDXG
-86.51
51. MDxHealth MDXH
-87.82
52. bioAffinity Technologies BIAF
-88.45
53. Neuronetics STIM
-92.42
54. Biodesix BDSX
-92.64
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.85
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.

If you accept cookies, we use them to improve and personalize your experience. Manage Cookies